A simple move from one class of inhibitor to another could decrease your risk of developing life-threatening diseases.
Activist Jim Chud lived with HIV for decades. Before his death, he open up with Plus about the AIDS crisis, future of HIV, and what he's learned.
Drug-resistant strains of HIV are becoming more common. Here’s the 411 on what you need to know to suppress the viral uprising.
Can this drug help long-term survivors become undetectable while also improving their immune system?
A two-drug regimen for those just starting treatment has moved closer to FDA approval.
And rebuilt his life along the way.
Ibalizumab is designed to help when other drugs fail.
